Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants.

Literature DB >> 33289818

Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants.

Giancarlo Natalucci¹, Bea Latal², Brigitte Koller¹, Christoph Rüegger¹, Beate Sick³, Leonhard Held³, Jean-Claude Fauchère¹.

Abstract

Entities: Gene Species

Mesh：

Substances：

Year: 2020 PMID： 33289818 PMCID： PMC7724553 DOI： 10.1001/jama.2020.19395

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

× No keyword cloud information.

6 in total

1. Preschool Assessment of Preterm Infants Treated With Darbepoetin and Erythropoietin.

Authors: Robin K Ohls; Daniel C Cannon; John Phillips; Arvind Caprihan; Shrena Patel; Sarah Winter; Michael Steffen; Ronald A Yeo; Richard Campbell; Susan Wiedmeier; Shawna Baker; Sean Gonzales; Jean Lowe
Journal: Pediatrics Date: 2016-02-15 Impact factor: 7.124

2. Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants.

Authors: Jean-Claude Fauchère; Brigitte M Koller; Alois Tschopp; Christof Dame; Christoph Ruegger; Hans Ulrich Bucher
Journal: J Pediatr Date: 2015-04-08 Impact factor: 4.406

Review 3. Prophylactic Early Erythropoietin for Neuroprotection in Preterm Infants: A Meta-analysis.

Authors: Hendrik S Fischer; Nora J Reibel; Christoph Bührer; Christof Dame
Journal: Pediatrics Date: 2017-04-07 Impact factor: 7.124

4. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.

Authors: Giancarlo Natalucci; Beatrice Latal; Brigitte Koller; Christoph Rüegger; Beate Sick; Leonhard Held; Hans Ulrich Bucher; Jean-Claude Fauchère
Journal: JAMA Date: 2016-05-17 Impact factor: 56.272

5. A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants.

Authors: Sandra E Juul; Bryan A Comstock; Rajan Wadhawan; Dennis E Mayock; Sherry E Courtney; Tonya Robinson; Kaashif A Ahmad; Ellen Bendel-Stenzel; Mariana Baserga; Edmund F LaGamma; L Corbin Downey; Raghavendra Rao; Nancy Fahim; Andrea Lampland; Ivan D Frantz Iii; Janine Y Khan; Michael Weiss; Maureen M Gilmore; Robin K Ohls; Nishant Srinivasan; Jorge E Perez; Victor McKay; Phuong T Vu; Jean Lowe; Karl Kuban; T Michael O'Shea; Adam L Hartman; Patrick J Heagerty
Journal: N Engl J Med Date: 2020-01-16 Impact factor: 91.245

6. Early erythropoiesis-stimulating agents in preterm or low birth weight infants.

Authors: Arne Ohlsson; Sanjay M Aher
Journal: Cochrane Database Syst Rev Date: 2020-02-11

6 in total

7 in total

1. Association between Term Equivalent Brain Magnetic Resonance Imaging and 2-Year Outcomes in Extremely Preterm Infants: A Report from the Preterm Erythropoietin Neuroprotection Trial Cohort.

Authors: Dennis E Mayock; Semsa Gogcu; Mihai Puia-Dumitrescu; Dennis W W Shaw; Jason N Wright; Bryan A Comstock; Patrick J Heagerty; Sandra E Juul
Journal: J Pediatr Date: 2021-08-26 Impact factor: 6.314

Neurodevelopmental Outcomes at Age 5 Years After Prophylactic Early High-Dose Recombinant Human Erythropoietin for Neuroprotection in Very Preterm Infants.

1. Preschool Assessment of Preterm Infants Treated With Darbepoetin and Erythropoietin.

2. Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants.

Review 3. Prophylactic Early Erythropoietin for Neuroprotection in Preterm Infants: A Meta-analysis.

4. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.

5. A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants.

6. Early erythropoiesis-stimulating agents in preterm or low birth weight infants.

1. Association between Term Equivalent Brain Magnetic Resonance Imaging and 2-Year Outcomes in Extremely Preterm Infants: A Report from the Preterm Erythropoietin Neuroprotection Trial Cohort.

Review 2. Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use.

Review 3. Preventing Brain Injury in the Preterm Infant-Current Controversies and Potential Therapies.

Review 4. Can Erythropoietin Reduce Hypoxemic Neurological Damages in Neonates With Congenital Heart Defects?

5. Endogenous erythropoietin at birth is associated with neurodevelopmental morbidity in early childhood.

Review 6. Prophylactic Erythropoietin for Neuroprotection in Very Preterm Infants: A Meta-Analysis Update.

7. Expression and role of P-element-induced wimpy testis-interacting RNA in diabetic-retinopathy in mice.